Navigation Links
Daily Intake of 'Yakult' Is Efficacious in Reducing Incidence of Acute Diarrhea in Young Children
Date:8/20/2010

TOKYO, Aug. 20 /PRNewswire/ -- YAKULT HONSHA CO., LTD. announced on August 20 that its collaborative study on the incidence of acute diarrhea with the National Institute of Cholera and Enteric Diseases in Kolkata, India, showed that daily intake of "Yakult" is efficacious in reducing the incidence of diarrhea in young children.

An unprecedented large-scale study, involving 3,585 children residing in an urban slum community in Kolkata, was conducted. As a result, "Yakult" was shown to be efficacious in reducing the incidence of acute diarrhea in young children and the difference was statistically significant. The demonstration that the continued intake of "Yakult" is effective in improving the gastrointestinal symptoms of the general public strongly corroborates the significance of drinking "Yakult."

These results were published on the "Epidemiology and Infection" website and the ePub is available on PubMed.

YAKULT HONSHA is engaged in research on probiotics, which refer to living microorganisms that confer a benefit on the host (people, etc.) by improving the balance of intestinal flora. A representative probiotic strain is Lactobacillus casei strain Shirota (YIT9029), which, in addition to an intestinal regulation action, has been verified in many published papers to have immunoregulatory actions such as helping to suppress the recurrence of superficial bladder cancer and reduce allergy symptoms. Hereafter, YAKULT HONSHA will continue to actively promote research on utilizing the remarkable power of microorganisms for the benefit of people's health.

Overview of Study

The number of children aged 5 years and under that die annually throughout the world is 8.80 million, and the country that has the most deaths is India (approximately 1.83 million children per year). It is reported that diarrhea is the cause in 13% of the deaths in children aged 5 years and under in India (Black RE et al, Lancet. 2010. 375: 1969-1987).

A double-blind randomized controlled field trial involving 3,585 children aged between 1 and 5 years was carried out in Kolkata, India. The participating children were given either "Yakult" or a placebo drink daily for 12 weeks to observe the incidence of acute diarrhea and pathogenic microbes in the stool.

The results showed that the proportion of children suffering from diarrhea was significantly lower in the "Yakult" group (608 out of 1,802) compared to the placebo group (674 out of 1,783). Moreover, the incidence of diarrhea was lower in the "Yakult" group (0.88/child/year) compared to the placebo group (1.029/child/year) and the difference was statistically significant (p less than 0.01). The analysis of pathogenic bacterial, viral and parasitic agents in the children with diarrhea resulted in the lower detection rate of Aeromonas spp and Cryptosporidium spp in the Yakult group compared to the placebo group.

*The placebo drink did not contain Lactobacillus casei strain Shirota. The taste and color of both the placebo drink and "Yakult" were similar. By comparing the effects of intake of each drink, the efficacy of "Yakult" can be scientifically measured.Contact:  Isamu Sasaoka  PR Department  YAKULT HONSHA CO., LTD.  Phone: +81-3-3574-8920 (Japanese and English Only)  E-mail: strain-shirota@yakult.co.jp (Japanese and English Only)  URL: http://www.yakult.co.jp/english/index.html  Michael Eric D. S. Ong  YAKULT PHILIPPINES, INC.  Phone: +63-2-521-1722  E-mail: micong@yakult.com.ph  Kuek Kok Ti  PR & Advertising Dept.  YAKULT (SINGAPORE) PTE., LTD.  Phone: +65-6756-1033  E-mail: yakult@pacific.net.sg  Dinah Woon  PR Dept.  YAKULT AUSTRALIA PTY. LTD.  Phone: +61-3-9238-4700  E-mail: dwoon@yakult.com.au  Mazlyn Mena binti Mustapha  PR & Science Dept.  YAKULT (MALAYSIA) SDN. BHD.  Phone: +60-3-5569-8960  E-mail: customerservice@yakult.com.my  Shefali Sapra  Corporate Communications  YAKULT DANONE INDIA PRIVATE LIMITED  Phone: +91-11-4062-6262  E-mail: shefali.sapra@yakult.co.in  Yasumi Kimura  R&D Dept.  YAKULT S/A IND. E. COM.  Phone: +55-11-5584-4700  E-mail: yasumi.kimura@yakult.com.br  Jiang Haitian  PR Department  Yakult (China) Corporation  Phone: +86-21-5010-8358  E-mail: jiang-haitian@yakult.com.cn
'/>"/>

SOURCE YAKULT HONSHA CO., LTD.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy
2. New Data Published in Neurology Show Once-Daily Lamictal XR Significantly Reduced Partial Seizures in Patients with Epilepsy
3. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
4. Potent Hepatitis C Virus Inhibitors Show Efficacy and Potential for Once Daily Dosing in Preclinical Studies
5. ISTA Pharmaceuticals Presents Results from Two Phase III Clinical Trials of Xibrom(TM) QD (Once-daily) Formulation at the American Academy of Ophthalmology Annual Meeting
6. Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept)
7. Voices to Unite in Los Angeles for 6,000 Children Orphaned Daily
8. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
9. Anthera Announces Preliminary Positive Results From Once-Daily A-002 Phase II Cardiovascular Trial
10. CASTLE Study Showed Similar Efficacy Between Once-Daily REYATAZ(R) (atazanavir sulfate)/ritonavir and Twice-Daily lopinavir/ritonavir at 48 Weeks in Previously Untreated HIV-Infected Adult Patients
11. U.S. Census Bureau Daily Feature for March 11
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... 2017  As National Nutrition Month approaches, USA Medical ... is helping people live healthier lives by providing ... programs in all 50 states including:  Texas Prescription ... California Prescription Assistance Program . USA Medical ... for nutritious eating habits: ...
(Date:2/23/2017)... NEW YORK , February 23, 2017 ... mixed end of day as four out of nine sectors ... and one sector managed a flat closing. Major US indices ... NASDAQ Composite ended the day at 5,860.63, slightly down by ... finish at 20,775.60; and the S&P 500 closed at 2,362.82, ...
(Date:2/23/2017)... 23, 2017  Spheryx, Inc. will present ... at PittCon 2017 Conference and Exposition at ... world,s largest annual premier conference and exposition ... array of industry, academic and government communities ... food safety, environmental, bioterrorism and other emerging ...
Breaking Medicine Technology:
(Date:2/23/2017)... ... February 23, 2017 , ... On February ... a letter to withdraw previous guidance issued by the Obama Administration ... guidance issued in May 2016 by the Obama Administration came in response to ...
(Date:2/23/2017)... ... 2017 , ... Los Angeles-based weight loss surgeon Michael Feiz, M.D., F.AC.S. will ... to Hot,” which will begin airing on February 24, 2017. The show chronicles the ... 2012 reality television series, “Here Comes Honey Boo Boo.” The earlier series from TLC ...
(Date:2/23/2017)... ... February 23, 2017 , ... Dr. David Mahon leads Siena Dental, a ... Mahon was named a 2017 Top Patient Rated Henderson Dentist by Find ... that recognizes local physicians and dentists who have earned high ratings and superior patient ...
(Date:2/23/2017)... ... February 23, 2017 , ... The Center ... Rhode Island Consortium for Autism Research and Treatment (RI-CART) and Cinemaworld to present ... spectrum disorder (ASD) to see films in an environment that accommodates their unique ...
(Date:2/23/2017)... ... , ... HealthPostures, the desk for standing designer headquartered in Prior Lake, Minnesota ... Minneapolis Home and Garden Show which is being held February 24 through 26 and ... the Minneapolis Convention Center. , From its broad line of sit stand desk ...
Breaking Medicine News(10 mins):